Marco de Boer
CEO & Co-founder, NTrans Technologies
Marco de Boer is CEO and co-founder of NTrans Technologies. He contributes his experience in the commercialization of biological and biomedical innovations, which includes the commercial development of platforms for the targeted delivery of bioactive molecules. In addition to his role as COO at Crossbeta Biosciences BV, prior to founding NTrans Technologies, Dr. Marco de Boer held several management positions: Head of Research at to-BBB, Head of Bioprocessing at Kerry I&F, Director Biomolecules at Isogen Life Science, and Research Manager at Unilever Research, Vlaardingen. Marco received an MBA from the Nyenrode Business University.